Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation

被引:7
作者
Vongtama, R
Lee, M
Kim, B
Sercarz, J
Lin, K
Suchard, MA
Lee, SP
Juillard, G
机构
[1] Univ Calif Los Angeles, Dept Radiat Oncol, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Otolaryngol, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Biomath, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Kaiser Permanente, Los Angeles, CA USA
关键词
radiation therapy; neck dissection; neoplasms; squamous cell;
D O I
10.1097/00130404-200411000-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemoradiation is increasingly becoming the standard of care for node-positive squamous cell cancer of the head and neck. Response to chemoradiation for clinically node-positive disease in the neck is often difficult to ascertain because clinical response may or may not be predictive of pathological response. This often leads to uncertainty about the necessity of a functional neck dissection after chemoradiation. In this study, we retrospectively analyzed a cohort of node-positive patients to examine pathological response as well as clinical outcome after chemoradiation with or without functional neck dissection. METHODS Using the radiation oncology records from 1993 until 2003, a population of 420 patients with squamous cell cancer of the head and neck were identified. Of these, 34 patients were clinically node positive at,the time of diagnosis and underwent chemoradiation as their primary therapy. All patients received a concurrent platinum-based regimen. Median radiation dose to gross neck disease was 68.4 Gy (range: 50.4-73.8 Gy). RESULTS Median follow-up time was 25 months (range: 4-88 months). Patients with a complete response (17/34, 50%) after receiving 50 Gy finished the full course of therapy but did not undergo functional neck dissection. Only one patient (1/17) in this observation group experienced relapse in the neck. Patients with a partial response who received 50 Gy (17/34) completed therapy and underwent functional neck dissection, regardless of response at the end of therapy. Fifty percent (3/6) with positive pathology had a regional relapse in the neck. whereas on, 1/11 patients with negative pathology relapsed in the neck. T his result compared favorably with those who were observed after chemoradiation. CONCLUSIONS Clinical response at 50 Gy can be an effective means of selecting patients for functional neck dissection. Patients with complete response at 50 Gy may be observed with a low regional recurrence rate. Those patients with a partial response should undergo adjuvant neck dissection.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 7 条
[1]   Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].
Al-Sarraf, M ;
LeBlanc, M ;
Giri, PGS ;
Fu, KK ;
Cooper, J ;
Vuong, T ;
Forastiere, AA ;
Adams, G ;
Sakr, WA ;
Schuller, DE ;
Ensley, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317
[2]   Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer [J].
Brizel, DM ;
Prosnitz, RG ;
Hunter, S ;
Fisher, SR ;
Clough, RL ;
Downey, MA ;
Scher, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05) :1418-1423
[3]   Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma [J].
Calais, G ;
Alfonsi, M ;
Bardet, E ;
Sire, C ;
Germain, T ;
Bergerot, P ;
Rhein, B ;
Tortochaux, J ;
Oudinot, P ;
Bertrand, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) :2081-2086
[4]   PROGNOSTIC VALUE OF TUMOR-REGRESSION DURING RADIOTHERAPY FOR HEAD AND NECK-CANCER - A PROSPECTIVE-STUDY [J].
JAULERRY, C ;
DUBRAY, B ;
BRUNIN, F ;
RODRIGUEZ, J ;
POINT, D ;
BLASZKA, B ;
ASSELAIN, B ;
MOSSERI, V ;
BRUGERE, J ;
COSSET, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (02) :271-279
[5]   Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck [J].
Mendenhall, WM ;
Villaret, DB ;
Amdur, RJ ;
Hinerman, RW ;
Mancuso, AA .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (11) :1012-1018
[6]   Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative pet scan after definitive radiation therapy? [J].
Rogers, JW ;
Greven, KM ;
McGuirt, WF ;
Keyes, JW ;
Williams, DW ;
Watson, NE ;
Geisinger, K ;
Cappellari, JO .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03) :694-697
[7]   The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma [J].
Yao, M ;
Graham, MM ;
Hoffman, HT ;
Smith, RB ;
Funk, GF ;
Graham, SM ;
Dornfeld, KJ ;
Skwarchuk, M ;
Menda, Y ;
Buatti, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04) :1001-1010